Transcription-dependent cohesin repositioning rewires chromatin loops in cellular senescence.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
27 11 2020
Historique:
received: 25 10 2019
accepted: 30 10 2020
entrez: 28 11 2020
pubmed: 29 11 2020
medline: 15 12 2020
Statut: epublish

Résumé

Senescence is a state of stable proliferative arrest, generally accompanied by the senescence-associated secretory phenotype, which modulates tissue homeostasis. Enhancer-promoter interactions, facilitated by chromatin loops, play a key role in gene regulation but their relevance in senescence remains elusive. Here, we use Hi-C to show that oncogenic RAS-induced senescence in human diploid fibroblasts is accompanied by extensive enhancer-promoter rewiring, which is closely connected with dynamic cohesin binding to the genome. We find de novo cohesin peaks often at the 3' end of a subset of active genes. RAS-induced de novo cohesin peaks are transcription-dependent and enriched for senescence-associated genes, exemplified by IL1B, where de novo cohesin binding is involved in new loop formation. Similar IL1B induction with de novo cohesin appearance and new loop formation are observed in terminally differentiated macrophages, but not TNFα-treated cells. These results suggest that RAS-induced senescence represents a cell fate determination-like process characterised by a unique gene expression profile and 3D genome folding signature, mediated in part through cohesin redistribution on chromatin.

Identifiants

pubmed: 33247104
doi: 10.1038/s41467-020-19878-4
pii: 10.1038/s41467-020-19878-4
pmc: PMC7695716
doi:

Substances chimiques

CCCTC-Binding Factor 0
Cell Cycle Proteins 0
Chromatin 0
Chromosomal Proteins, Non-Histone 0
Interleukin-1 0
Tumor Necrosis Factor-alpha 0
ras Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6049

Subventions

Organisme : Medical Research Council
ID : MR/L007150/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C9545/A29580
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J004480/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 215912/Z/19/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T016787/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12022/10
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S013466/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015724/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 105367/Z/14/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M013049/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010013/1
Pays : United Kingdom

Références

Curr Biol. 2015 Jun 29;25(13):1694-706
pubmed: 26051894
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Nat Commun. 2019 Dec 12;10(1):5688
pubmed: 31831736
Nat Rev Genet. 2018 Dec;19(12):789-800
pubmed: 30367165
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17031-6
pubmed: 19805069
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Front Genet. 2014 Apr 10;5:75
pubmed: 24782889
Nat Cell Biol. 2008 Jul;10(7):825-36
pubmed: 18516091
BMC Bioinformatics. 2015 Aug 19;16:258
pubmed: 26283514
Nat Genet. 2017 Oct;49(10):1522-1528
pubmed: 28805829
Nucleic Acids Res. 2016 Nov 16;44(20):e153
pubmed: 27484474
Bioinformatics. 2017 Jul 15;33(14):2199-2201
pubmed: 28369339
Cell. 2019 Oct 31;179(4):813-827
pubmed: 31675495
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Cell. 2018 Sep 6;174(6):1522-1536.e22
pubmed: 30146161
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Nat Rev Cancer. 2019 Aug;19(8):439-453
pubmed: 31235879
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Cell. 2014 Dec 18;159(7):1665-80
pubmed: 25497547
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Nat Protoc. 2012 Sep;7(9):1728-40
pubmed: 22936215
Sci Adv. 2016 Feb 05;2(2):e1500882
pubmed: 26989773
Biochim Biophys Acta. 2012 Mar;1819(3-4):322-31
pubmed: 21839870
Mol Cell. 2018 May 17;70(4):730-744.e6
pubmed: 29706538
Genome Res. 2016 Nov;26(11):1478-1489
pubmed: 27633323
Genome Res. 2015 Apr;25(4):582-97
pubmed: 25752748
Nat Genet. 2015 Jun;47(6):598-606
pubmed: 25938943
Cell Struct Funct. 2008;33(1):61-73
pubmed: 18227620
PLoS Biol. 2004 Sep;2(9):E259
pubmed: 15309048
Nat Commun. 2018 Oct 10;9(1):4189
pubmed: 30305613
Genome Res. 2017 Nov;27(11):1939-1949
pubmed: 28855260
Genes Dev. 2019 Feb 1;33(3-4):127-143
pubmed: 30709901
Nat Cell Biol. 2016 Sep;18(9):979-92
pubmed: 27525720
Cell. 2006 Aug 11;126(3):503-14
pubmed: 16901784
Cell Rep. 2015 Feb 3;10(4):471-83
pubmed: 25640177
Nature. 2013 Nov 14;503(7475):290-4
pubmed: 24141950
Genes Dev. 2009 Apr 1;23(7):798-803
pubmed: 19279323
Cell. 2016 Nov 17;167(5):1369-1384.e19
pubmed: 27863249
Nat Commun. 2018 May 9;9(1):1840
pubmed: 29743479
Mol Cell. 2017 Sep 21;67(6):1037-1048.e6
pubmed: 28890333
Mol Cell. 2012 Jul 27;47(2):203-14
pubmed: 22795131
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Methods. 2009 Jul;48(3):240-8
pubmed: 19275939
PLoS Biol. 2012 Jan;10(1):e1001244
pubmed: 22272186
Mol Cell. 2020 May 7;78(3):522-538.e9
pubmed: 32220303
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Genes Dev. 2013 Aug 15;27(16):1800-8
pubmed: 23964094
Sci Rep. 2019 Jun 27;9(1):9354
pubmed: 31249361
PLoS Comput Biol. 2017 Jul 19;13(7):e1005665
pubmed: 28723903
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Genome Res. 2018 Feb 2;:
pubmed: 29429976
Nature. 2004 Jul 29;430(6999):573-8
pubmed: 15229615
J Vis Exp. 2018 Jun 28;(136):
pubmed: 30010637
Cancer Discov. 2016 Jun;6(6):612-29
pubmed: 27099234
PLoS One. 2013 Nov 08;8(11):e79895
pubmed: 24260314
Genome Biol. 2015 Aug 26;16:175
pubmed: 26306623
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Genome Res. 2014 Dec;24(12):1905-17
pubmed: 25228660
Methods Mol Biol. 2017;1515:257-271
pubmed: 27797085
Genome Biol. 2015 Dec 01;16:259
pubmed: 26619908
Nat Commun. 2018 Mar 20;9(1):1156
pubmed: 29559685
Genes Dev. 2010 Nov 15;24(22):2463-79
pubmed: 21078816
J Clin Invest. 2018 Apr 2;128(4):1238-1246
pubmed: 29608137
Nature. 2017 Apr 27;544(7651):503-507
pubmed: 28424523
Nat Methods. 2012 Oct;9(10):999-1003
pubmed: 22941365
Mol Cell. 2007 Jul 20;27(2):183-96
pubmed: 17643369
Nat Rev Genet. 2019 Aug;20(8):437-455
pubmed: 31086298
Cell. 2008 Mar 21;132(6):983-95
pubmed: 18358811
Nat Cell Biol. 2013 Aug;15(8):978-90
pubmed: 23770676

Auteurs

Ioana Olan (I)

Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, UK.

Aled J Parry (AJ)

Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, UK.
Epigenetics Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK.

Stefan Schoenfelder (S)

Epigenetics Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK.
Nuclear Dynamics Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK.

Masako Narita (M)

Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, UK.

Yoko Ito (Y)

Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, UK.

Adelyne S L Chan (ASL)

Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, UK.

Guy St C Slater (GSC)

Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, UK.

Dóra Bihary (D)

MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

Masashige Bando (M)

Laboratory of Genome Structure and Function, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan.

Katsuhiko Shirahige (K)

Laboratory of Genome Structure and Function, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan.

Hiroshi Kimura (H)

Cell Biology Centre, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, Japan.

Shamith A Samarajiwa (SA)

MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

Peter Fraser (P)

Nuclear Dynamics Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK. pfraser@bio.fsu.edu.
Department of Biological Science, Florida State University, Tallahassee, FL, USA. pfraser@bio.fsu.edu.

Masashi Narita (M)

Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, UK. masashi.narita@cruk.cam.ac.uk.
Tokyo Tech World Research Hub Initiative (WRHI), Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, Japan. masashi.narita@cruk.cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH